SABS
Price
$1.75
Change
+$0.06 (+3.55%)
Updated
Jun 30, 04:42 PM (EDT)
Capitalization
16.3M
TECX
Price
$19.82
Change
+$0.02 (+0.10%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
370.09M
Interact to see
Advertisement

SABS vs TECX

Header iconSABS vs TECX Comparison
Open Charts SABS vs TECXBanner chart's image
SAB Biotherapeutics
Price$1.75
Change+$0.06 (+3.55%)
Volume$115
Capitalization16.3M
Tectonic Therapeutic
Price$19.82
Change+$0.02 (+0.10%)
Volume$3.23K
Capitalization370.09M
SABS vs TECX Comparison Chart in %
Loading...
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SABS vs. TECX commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SABS is a Buy and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (SABS: $1.69 vs. TECX: $19.80)
Brand notoriety: SABS and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SABS: 46% vs. TECX: 779%
Market capitalization -- SABS: $16.3M vs. TECX: $370.09M
SABS [@Biotechnology] is valued at $16.3M. TECX’s [@Biotechnology] market capitalization is $370.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SABS’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 1 green FA rating(s).

  • SABS’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 1 green, 4 red.
According to our system of comparison, both SABS and TECX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SABS’s TA Score shows that 3 TA indicator(s) are bullish while TECX’s TA Score has 3 bullish TA indicator(s).

  • SABS’s TA Score: 3 bullish, 4 bearish.
  • TECX’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, SABS is a better buy in the short-term than TECX.

Price Growth

SABS (@Biotechnology) experienced а -5.59% price change this week, while TECX (@Biotechnology) price change was -0.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

SABS is expected to report earnings on May 09, 2025.

TECX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($370M) has a higher market cap than SABS($16.3M). SABS (-55.458) and TECX (-57.115) have similar YTD gains . SABS has higher annual earnings (EBITDA): -30.38M vs. TECX (-56.94M). TECX has more cash in the bank: 306M vs. SABS (12.9M). TECX has less debt than SABS: TECX (2.63M) vs SABS (6.78M). SABS (0) and TECX (0) have equivalent revenues.
SABSTECXSABS / TECX
Capitalization16.3M370M4%
EBITDA-30.38M-56.94M53%
Gain YTD-55.458-57.11597%
P/E RatioN/AN/A-
Revenue00-
Total Cash12.9M306M4%
Total Debt6.78M2.63M258%
FUNDAMENTALS RATINGS
TECX: Fundamental Ratings
TECX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SABSTECX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
71%
Bullish Trend 6 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
SABS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HFEIX56.200.55
+0.99%
Janus Henderson European Focus I
BLYRX35.330.28
+0.80%
American Beacon Man Lg Cp Growth R6
JSGAX28.550.21
+0.74%
JHancock U.S. Growth A
ARSKX71.270.50
+0.71%
Archer Stock
JATSX64.350.41
+0.64%
Janus Henderson Glb Tech and Innovt S